Achieve Life Sciences (ACHV) Depreciation & Amortization (CF) (2010 - 2026)

Achieve Life Sciences (ACHV) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $57000.0 in Q1 2026.

• Quarterly Depreciation & Amortization (CF) fell 8.06% year-over-year to $57000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $223000.0 (down 4.7% YoY) and the FY2025 annual result came in at $228000.0, changed 0.44% from the prior year.
• Depreciation & Amortization (CF) steadied at $57000.0 in Q1 2026, from $57000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $65000.0 in Q4 2022 to a low of $54000.0 in Q3 2025.
• A 5-year average of $57529.4 and a median of $57000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) retreated 12.31% — and 2025, when it rose 8.77%.
• Tracing ACHV's Depreciation & Amortization (CF) over 5 years: stood at $65000.0 in 2022, then dropped by 12.31% to $57000.0 in 2023, then advanced by 1.75% to $58000.0 in 2024, then declined by 1.72% to $57000.0 in 2025, then changed by 0.0% to $57000.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $57000.0 (Q1 2026), $57000.0 (Q4 2025), and $54000.0 (Q3 2025), per Business Quant data.